Shreya Pharma (India) Private Limited
About Shreya Pharma (India) Private Limited
Data last updated:
Shreya Pharma (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Shreya Life Sciences Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 April 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2001PTC131489. Its GSTIN is 27AAFCS2917N1ZY (Maharashtra). The company holds 15 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.05 Lakh. It was formerly known as Serena Pharma Private Limited. It is led by directors Sujit Kumar Singh and Himanshu Baldev Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shreya House 4th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, India – 400099.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.2 Cr. For the same year it recorded a net profit of ₹1.2 Cr (net margin 6.3%) and EBITDA of ₹1.62 Cr (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 76% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shreya Pharma (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShreya House 4th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, India – 400099
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shreya Pharma (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shreya Pharma (India) Private Limited
FY 2025 filings availableShreya Pharma (India) Private Limited reported revenue of ₹19.2 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 76% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹19.2 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.62 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shreya Pharma (India) Private Limited, buy the company report.
Board of directors of Shreya Pharma (India) Private Limited
Shreya Pharma (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujit Kumar Singh | Director | 03 Apr 2001 | 25 Years 6 Months | Current |
| Himanshu Baldev Singh | Director | 06 Nov 2009 | 16 Years 11 Months | Current |
Peer comparison
Shreya Pharma (India) Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synovia Life Sciences Private Limited | ₹19.44 Cr (FY 2025) | 9.0% | Jaipur, Rajasthan, India | |||
| Matteo Healthcare Private Limited | ₹19.41 Cr (FY 2025) | 30.0% | Indore, Madhya Pradesh, India | |||
| Vinayak Remedies Limited | ₹19.4 Cr (FY 2024) | -15.0% | Delhi, India | |||
| Shreya Pharma (India) Private Limitedthis company | ₹19.2 Cr (FY 2025) | ₹1.2 Cr | 6.3% | Mumbai, Maharashtra, India | ||
| Alaukik Healthcare Private Limited | ₹19.07 Cr (FY 2024) | 56.0% | Akola, Maharashtra, India | |||
| Hippocrat Biotech Private Limited | ₹19.07 Cr (FY 2024) | 49.0% | Thane, Maharashtra, India | |||
| Lakshmi Farmachem Private Limited | ₹19.03 Cr (FY 2024) | 40.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Shreya Pharma (India) Private Limited, buy the company report.
Auditor
Shreya Pharma (India) Private Limited is audited by B R A H M & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R A H M & ASSOCIATES | FY 2024 | 102153W |
Shareholding
The shareholding of Shreya Pharma (India) Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shreya Pharma (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shreya Pharma (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shreya Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shreya Pharma (India) has 15 GST registrations: 15 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCS2917N1ZY | Maharashtra | Active | 01 Jul 2017 |
| 05AAFCS2917N1Z4 | Uttarakhand | Active | 17 Oct 2017 |
| 22AAFCS2917N1Z8 | Chattisgarh | Active | 31 Dec 2024 |
| 18AAFCS2917N1ZX | Assam | Active | 10 Jan 2025 |
To see the full GST registrations and return filing status of Shreya Pharma (India) Private Limited, buy the company report.
Recent activity
Shreya Pharma (India) Private Limited has 5 board changes on record since 2001: 2 appointments and 3 cessations. The latest: Sheel Kumar Dhananjay Singh ceased to be Director on 10 Mar 2019.
Frequently asked questions
Shreya Pharma (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 April 2001 (25+ years old) and is registered under CIN U24239MH2001PTC131489.
Shreya Pharma (India) has 2 current directors:
- Sujit Kumar Singh - Director
- Himanshu Baldev Singh - Director
The latest financial statements of Shreya Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shreya Pharma (India) is 27AAFCS2917N1ZY, registered in Maharashtra. The company has 15 GST registrations in all, of which 15 are active. Other active GSTINs include 05AAFCS2917N1Z4 (Uttarakhand), 22AAFCS2917N1Z8 (Chattisgarh), 18AAFCS2917N1ZX (Assam).
The CIN (Corporate Identification Number) of Shreya Pharma (India) is U24239MH2001PTC131489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreya Pharma (India) was incorporated on 03 April 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Shreya Pharma (India) by revenue are Synovia Life Sciences Private Limited, Matteo Healthcare Private Limited, Vinayak Remedies Limited, Alaukik Healthcare Private Limited, Hippocrat Biotech Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sheel Kumar Dhananjay Singh ceased to be Director on 10 Mar 2019. Himanshu Baldev Singh was appointed as Director on 06 Nov 2009. Radhe Krishan Nagpal ceased to be Director on 06 Nov 2009. Shreya Pharma (India) has 5 board changes on record in total.
The registered office of Shreya Pharma (India) is at Shreya House 4th Floor301A Pereira Hill Road Andheri West, Mumbai, Maharashtra, India – 400099.
Shreya Pharma (India) operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Shreya Pharma (India) is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
